Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product: |
Hexaxim |
|
Active Ingredients: |
Diphtheria toxoid, adsorbed 30Lf U equivalent to not less than 20IU Haemophilus influenzae type b polysaccharide 12mcg Hepatitis B virus surface antigen 10mcg Pertussis filamentous haemagglutinin 25mcg Pertussis toxoid, adsorbed 25mcg Polio virus type 1 40DAgU Polio virus type 2 8DAgU Polio virus type 3 32DAgU Tetanus toxoid, adsorbed 10Lf U equivalent to not less than 40IU |
|
Dosage Form: |
Suspension for injection |
|
New Zealand Sponsor: |
Sanofi-Aventis New Zealand Limited |
|
Manufacturers: |
Sanofi Pasteur SA, Marcy L'Etoile, France Sanofi Pasteur SA, Val-De-Reuil Cedex, France |
|
Product: |
Miacalcic |
|
Active Ingredient: |
Salcatonin 100IU/mL |
|
Dosage Form: |
Solution for injection |
|
New Zealand Sponsor: |
Emerge Health New Zealand Limited |
|
Manufacturers: |
Novartis Pharma Stein AG, Stein, Switzerland Solupharm Pharmaceutical Products GmbH & Co. KG, Melsungen, Germany |
|
Product: |
Rytmonorm |
|
Active Ingredient: |
Propafenone hydrochloride 150mg |
|
Dosage Form: |
Tablet |
|
New Zealand Sponsor: |
Mylan New Zealand Limited |
|
Manufacturers: |
Famar Lyon, Saint-Genis-Laval, France Mylan Laboratories Limited, Aurangabad, India |
Dated this 18th day of May 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on the 11th day of September 2013).